Abstract
The rapid outbreaks of lethal viruses necessitate the development of novel antiviral substance. Besides the conventional antiviral substances, biocompatible nanomaterials also have significant potential in combating the virus at various stages of infection. Carbon nanomaterials have an impressive record against viruses and can deal with many crucial healthcare issues. In accordance with the published literature, biocompatible carbon nanomaterials have a promising prospect as an antiviral substance. Subsequently, the antiviral properties of different carbon nanomaterials namely fullerene, carbon nanotube, carbon dot and graphene oxide have been reviewed.
Keywords: Fullerene, Carbon nanotube, Carbon dot, Graphene oxide, Antiviral, COVID-19
Graphical abstract
The world is facing an unprecedented medical emergency since December 2019 owing to a new strain of coronavirus which is named as severe acute respiratory-related coronavirus 2 (SARS-CoV-2) [1]. Various detection strategies are being employed to refrain off the transmission chain of the disease which is mainly based on immunological assays or using amplification techniques. The methods involving immunological assays suffer from the drawback of the requirement of complex production of antibodies and recombinant proteins while amplification-based techniques require expensive instruments and skilled personnel [2]. To overcome the inherent problems of the standard detection techniques many new nanotechnology-based approaches have evolved [3,4] incorporating carbon nanomaterials [5]. However, mere detection is not enough to break the chain, the development of a new generation of antiviral tools is urgently needed to combat this pandemic.
Antiviral substances can be categorised as virostatic and virucidal [6]. The working of virostatic substances is based on a binding mechanism and they act in the early stages of infection by reducing viral replication rate, while virucidal substances can deactivate the virus permanently. These antiviral substances are of the order of nanometer and they interact well with nanosized viruses via biochemical interaction. In this regard, carbon nanomaterials show great potential to be used as an antiviral substance because of their novel physio-chemical characteristic [7].
The first carbon nanomaterial fullerene was discovered in 1985 by Prof Smalley's group and it is also the first candidate to be tested as the antiviral substance in 1993 by Sijbesma et al. [8]. It was found that fullerenes fit well into the active sites of the human immunodeficiency virus (HIV) and can block the encoded enzymes. Later on, several researchers have synthesised different tailor-made fullerene derivatives to achieve higher inhibition of HIV-1 maturation [9], HIV-RT [10] or HIV-1 protease [11]. In some cases, the solubility of antiviral substance is required and interestingly it is possible to synthesise water-soluble fullerene while keeping their antiviral activity intact [12]. Kornev et al. [13] developed water-soluble polycarboxylic derivatives of fullerene which showed pronounced antiviral activity against HIV and influenza A virus. Carboxylic derivatives of fullerene also have been effective to inhibit Herpes Simplex Virus and Cytomegalovirus [14]. Kataoka et al. [15] synthesised proline-type fullerene to inhibit Hepatitis C virus protease successfully. Falynskova et al. [16] produced a tailor-made fullerene compound fullerene-(tris-aminocaproic acid) hydrate to hinder the Respiratory Syncytial Virus multiplication in HEp-2 cell, however application time is crucial for effective inhibition of the virus. Fullerene derivatives are also able to inhibit the Zika Virus and Dengue viruses [17]. Non-derivatized fullerene is also employed for efficient inhibition of viruses like simian immunodeficiency virus and the Moloney murine leukemia virus (M-MuLV) [18]. Moreover, fullerene can produce singlet oxygen (1O2) upon illumination by visible light [19] (Fig 1 ). This property of fullerene has been utilized by several researchers for the inactivation of viruses [20,21] even in water [22] and can be used for the sanitization of indoor air [23]. Thus, fullerene can be effectively employed to combat RNA type viruses.
Fig. 1.
A ground-state fullerene absorbs a photon, transitions to the short-lived (nsec) excited singlet state that can undergo intersystem crossing to the long-lived (µsec) excited triplet state. The triplet fullerene can relax to ground state by emitting phosphorescence, but can also undergo energy transfer with ground state triplet oxygen (3O2) to form reactive singlet oxygen (1O2, Type 2) or else can undergo an electron transfer reaction to form HO•, superoxide and H2O2 (Type 1). These ROS (1O2 and HO•) can damage lipids, proteins and nucleic acids leading to the destruction of all types of microbial cells, and efficiently kill cancer cells and destroy tumors. (Reproduced with permission from Royal Society of Chemistry [53]).
Another carbon allotrope, namely carbon nanotube (CNT) was first reported in 1952 [24], but after the description provided by Ijima in 1991, [25] it gains worldwide attention. Krishnaraj et al. [26] theoretically studied the molecular interaction between CNT and HIV. Their results revealed that CNT has a high binding affinity towards the proteins of HIV, demonstrating the antiviral activity. Single wall carbon nanotubes (SWCNTs), both in pristine form and decorated with metal (Pt, Pd, Ni, Cu, Rh, or Ru) nanoparticles were examined to study the adsorption of hydrogen peroxide (as a representative of the ROS family) by Aasi et al. [27] employing density functional theory. The results exhibited that hydrogen peroxide is weakly physisorbed on pristine SWCNT while strong physisorption was found on metal decorated SWCNTs. Moreover, metal decorated SWCNTs showed long shelf lives which make it a potential candidate for designing the antiviral surfaces and personal protection equipment (PPE). Banerjee et al. [28] prepared porphyrin-conjugated multi-walled carbon nanotubes (MWCNTs) by attaching protoporphyrin IX to acid-functionalized MWCNTs. Under the illumination of visible light, the prepared material considerably suppressed the ability of Influenza A virus to infect mammalian cells. Differently functionalized MWCNTs were studied by Iannazzo et al. [29] for their in-vitro anti-HIV activity. The results revealed that hydrophilic functionality and water dispersibility of functionalized MWCNTs governed the antiviral activity against HIV. Henceforth, it can be seen that CNT can be potentially used for deactivation of RNA type viruses.
Carbon dots (CDs) were accidentally discovered by Xu et al. [30] in 2004 and later in 2006 Sun et al. produced stable photoluminescent carbon nanoparticles having different sizes and named as “Carbon Quantum Dots” (CQDs) [31]. On the other hand graphene quantum dot (GQD) was discovered in 2008 by Ponomarenko et al. [32]. There is a structural difference between GQD and CD. CDs are generally quasi-spherical in shape and are smaller than 10 nm in size, while GQD has graphene lattice having a size of less than 100 nm [33]. Barras et al. [34] reported that functionalized CDs with boronic acid can restrict the entry of herpes simplex virus type 1 (HSV-1) at its early stage. Functionalized CDs with boronic acid also have the potential to inhibit HIV-1 entry [35]. Du et al. [36] examined inhibition characteristics of CDs on RNA and DNA model type viruses. Pseudorabies virus (PRV) was considered as a DNA model type virus and porcine reproductive and respiratory syndrome virus (PRRSV) was used as an RNA model type virus for this study. They found that CDs induces interferon-α and inhibit virus replication for both RNA and DNA type viruses (Fig 2 ). Glycyrrhizic acid was used to synthesis CD by Tong et al. [37] and the prepared CDs depicted a broad spectrum of antiviral activity against various viruses like PRRSV, pseudorabies virus (PRV) and porcine epidemic diarrhea virus (PEDV). Lin et al. [38] derived CDs from curcumin (Cur-CQDs) through one-step dry heating and found that the obtained CDs possessed strong antiviral activity against enterovirus 71 (EV71) via scavenging free radicals and strong antioxidant activity. To examine the antiviral property of curcumin derived CDs for inhibition of coronavirus model type virus Ting et al. [39] used PEDV. It was revealed that the curcumin derived CDs inhibited the viral entry by changing the structure of virus surface proteins and reduced the viral replication via stimulation of the production of interferon-stimulating genes (ISGs). The effect of functionalization using boronic acid on seven types of CDs to inhibit human coronavirus was studied by Łoczechin et al. [40]. The derived carbon nanostructures depicted concentration-dependent virus inactivation at the viral replication step. Huang et al. [41] prepared benzoxazine monomer derived CDs and showed that the derived nanostructure possessed broad-spectrum antiviral ability against life-threatening flaviviruses (Japanese encephalitis, Zika, and dengue viruses) and non-enveloped viruses (porcine parvovirus and adenovirus-associated virus). Norovirus can also be inhibited by surface passivated CDs as reported by Dong et al. [42]. Ju et al. [43] reported that CDs are even effective for the inhibition of viral microRNA by regulating the proliferation and survival of virus-induced cancer cells. GQD has also has been used for inhibition of virus. Lannazzo et al. [44] synthesized water-soluble GQD by prolonged oxidation of multiwall carbon nanotube and used it for the inhibition of HIV RT.
Fig. 2.
Effect on PRRSV and PRV before (leftmost column) and after (rightmost column) the addition of carbon dots. (Reproduced with permission from Elsevier [36]).
After the first demonstration of easy isolation of graphene by Geim and Novoselov, from bulk graphite in 2004 [45], graphene and its derivatives have been widely used in different sectors of the medical industry (Fig 3 ). Sametband et al. [46] used graphene oxide (GO) derivatives to inhibit HSV-1 via viral attachment blocking. The GO blocked HSV-1 infections at relatively low concentrations and the charge density was the major factor affecting the inhibition of virus. Two typical enteric viruses, EV71 and Influenza A virus subtype (H9N2), were used as target viruses by Song et al. [47] for inhibition by GO and found that GO could completely remove the target viruses by destruction and disinfection properties. Yang et al. [48] functionalised GO with β-cyclodextrin and used it as an antiviral substance to inhibit RNA type respiratory syncytial virus. His-result showed that the functionalised GO can inactivate the virus directly. The photocatalytic activity of GO [49] has also been explored by the researchers for the inhibition of viruses. Hu et al. [50] prepared GO functioned aptamer and used it for successful photocatalysis of viruses via energy transfer under visible light illumination. Graphene-tungsten oxide composite thin films were synthesized by Akhavan et al. [51] which exhibited an outstanding photocatalytic performance in photoinactivation of bacteriophage MS2 viruses in the presence of visible light.
Fig. 3.
Schematic representation of the working principle. (A) The synthesis of functional nanomaterial composite; (B) the proposed inhibition mode of functional nanomaterials composite against RSV infection. (Reproduced with permission from Royal Society of Chemistry [48]).
In summary, SARS-CoV-2 belongs to the RNA virus family and has created a medical emergency worldwide because of its deadly nature and rapid transmission rate. To combat the present situation various carbon nanomaterials, like fullerene, CNT, CD, GQD and GO can be employed as antiviral substances because of their capability of inhibiting RNA type virus [52], biocompatibility and low toxicity. Thus, it can be believed that these unique carbon nanomaterials will pave the way to combat the fatal SARS-CoV-2 in near future.
Declaration of Competing Interest
All Authors declare no conflict interest.
References
- 1.Gorbalenya A.E., et al. The species severe acute respiratory syndrome-related coronavirus : classifying 2019-NCoV and naming it SARS-CoV-2. Nat. Microbiol. 2020;5(4):2. doi: 10.1038/s41564-020-0695-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Sheikhzadeh E., et al. Diagnostic techniques for COVID-19 and new developments. Talanta. 2020;220 doi: 10.1016/j.talanta.2020.121392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Jindal S., Gopinath P. Nanotechnology based approaches for combatting COVID-19 viral infection. Nano Express. 2020;1(2) doi: 10.1088/2632-959X/abb714. [DOI] [Google Scholar]
- 4.Weiss C., et al. Toward nanotechnology-enabled approaches against the COVID-19 pandemic. ACS Nano. 2020;14(6):6383–6406. doi: 10.1021/acsnano.0c03697. [DOI] [PubMed] [Google Scholar]
- 5.Ehtesabi H. Application of carbon nanomaterials in human virus detection. J. Sci.: Adv. Mate. Dev. 2020;5(4):436–450. doi: 10.1016/j.jsamd.2020.09.005. [DOI] [Google Scholar]
- 6.Cagno V., et al. Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism. Nat. Mater. 2018;17(2):195–203. doi: 10.1038/nmat5053. [DOI] [PubMed] [Google Scholar]
- 7.Hassan A.A., et al. In: Carbon Nanomaterials for Agri-Food and Environmental Applications. Abd-Elsalam K.A., editor. Elsevier; 2020. 23 - toxic and beneficial effects of carbon nanomaterials on human and animal health; pp. 535–555. Micro and Nano Technologies. [DOI] [Google Scholar]
- 8.Sijbesma R., et al. Synthesis of a fullerene derivative for the inhibition of HIV enzymes. J. Am. Chem. Soc. 1993;115(15):6510–6512. doi: 10.1021/ja00068a006. [DOI] [Google Scholar]
- 9.Castro E., et al. Characterization of new cationic N,N-Dimethyl[70]Fulleropyrrolidinium iodide derivatives as Potent HIV-1 Maturation Inhibitors. J. Med. Chem. 2016;59(24):10963–10973. doi: 10.1021/acs.jmedchem.6b00994. [DOI] [PubMed] [Google Scholar]
- 10.Yilmaz H., et al. Application of ligand- and receptor-based approaches for prediction of the HIV-RT inhibitory activity of fullerene derivatives. J. Nanopart. Res. 2016;18(5):123. doi: 10.1007/s11051-016-3429-7. [DOI] [Google Scholar]
- 11.Barzegar A., et al. 2D-QSAR study of fullerene nanostructure derivatives as potent HIV-1 protease inhibitors. Physica E. 2017;93:324–331. doi: 10.1016/j.physe.2017.06.016. [DOI] [Google Scholar]
- 12.Troshina O.A., et al. Chlorofullerene C60Cl6: a precursor for straightforward preparation of highly water-soluble polycarboxylic fullerene derivatives active against HIV. Org. Biomol. Chem. 2007;5(17):2783–2791. doi: 10.1039/B705331B. [DOI] [PubMed] [Google Scholar]
- 13.Kornev A.B., et al. Synthesis and antiviral activity of highly water-soluble polycarboxylic derivatives of [70]Fullerene. Chem. Commun. 2011;47(29):8298–8300. doi: 10.1039/C1CC12209F. [DOI] [PubMed] [Google Scholar]
- 14.Fedorova N.E., et al. Carboxylic fullerene C60 derivatives: efficient microbicides against herpes simplex virus and cytomegalovirus infections in vitro. Mendeleev Commun. 2012;22(5):254–256. doi: 10.1016/j.mencom.2012.09.009. [DOI] [Google Scholar]
- 15.Kataoka H., et al. Novel fullerene derivatives as dual inhibitors of Hepatitis C Virus NS5B Polymerase and NS3/4A Protease. Bioorg. Med. Chem. Lett. 2016;26(19):4565–4567. doi: 10.1016/j.bmcl.2016.08.086. [DOI] [PubMed] [Google Scholar]
- 16.Falynskova I.N., et al. Antiviral activity of fullerene-(Tris-Aminocaproic Acid) hydrate against respiratory syncytial virus in HEp-2 cell culture. Pharm. Chem. J. 2014;48(2):85–88. doi: 10.1007/s11094-014-1053-3. [DOI] [Google Scholar]
- 17.Ramos-Soriano J., et al. Synthesis of highly efficient multivalent disaccharide/[60]Fullerene nanoballs for emergent viruses. J. Am. Chem. Soc. 2019;141(38):15403–15412. doi: 10.1021/jacs.9b08003. [DOI] [PubMed] [Google Scholar]
- 18.Nacsa J., et al. Antiretroviral effects of nonderivatizcd C6o in vitro. Fullerene Sci. Technol. 1997;5(5):969–976. doi: 10.1080/15363839708013310. [DOI] [Google Scholar]
- 19.Arbogast J.W., et al. Photophysical properties of sixty atom carbon molecule (C60) J. Phys. Chem. 1991;95(1):11–12. doi: 10.1021/j100154a006. [DOI] [Google Scholar]
- 20.Käsermann F., Kempf C. Buckminsterfullerene and photodynamic inactivation of viruses. Rev. Med. Virol. 1998;8(3):143–151. doi: 10.1002/(sici)1099-1654(199807/09)8:3<143::aid-rmv214>3.0.co;2-b. 10.1002/(SICI)1099-1654(199807/09)8:3<143::AID−RMV214>3.0.CO;2-B. [DOI] [PubMed] [Google Scholar]
- 21.Käsermann F., Kempf C. Photodynamic inactivation of enveloped viruses by Buckminsterfullerene1for the described inactivation procedure, a patent application was submitted.1. Antiviral Res. 1997;34(1):65–70. doi: 10.1016/S0166-3542(96)01207-7. [DOI] [PubMed] [Google Scholar]
- 22.Snow S.D., Park K.E., Kim J.-.H. Cationic fullerene aggregates with unprecedented virus photoinactivation efficiencies in water. Environ. Sci. Technol. Lett. 2014;1(6):290–294. doi: 10.1021/ez5001269. [DOI] [Google Scholar]
- 23.Kim J., et al. Photosensitized production of singlet oxygen via C60 fullerene covalently attached to functionalized silica-coated stainless-steel mesh: remote bacterial and viral inactivation. Appl. Catal. B. 2020;270 doi: 10.1016/j.apcatb.2020.118862. [DOI] [Google Scholar]
- 24.Monthioux M., Kuznetsov V.L. Who should be given the credit for the discovery of carbon nanotubes? Carbon N Y. 2006;44(9):1621–1623. doi: 10.1016/j.carbon.2006.03.019. [DOI] [Google Scholar]
- 25.Iijima S. Helical microtubules of graphitic carbon. Nature. 1991;354(6348):56–58. doi: 10.1038/354056a0. [DOI] [Google Scholar]
- 26.Krishnaraj R.N., Chandran S., Pal P., Berchmans S. Investigations on the antiretroviral activity of carbon nanotubes using computational molecular approach. Comb. Chem. High Throughput Screen. 2014 doi: 10.2174/1386207317666140116110558. https://www.eurekaselect.com/119739/article [DOI] [PubMed] [Google Scholar]
- 27.Aasi A., et al. ‘Pt-, Rh-, Ru-, and Cu-single-wall carbon nanotubes are exceptional candidates for design of anti-viral surfaces: a theoretical study. Int. J. Mol. Sci. 2020;21(15):5211. doi: 10.3390/ijms21155211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Banerjee I., et al. Light-activated nanotube–porphyrin conjugates as effective antiviral agents. Nanotechnology. 2012;23(10) doi: 10.1088/0957-4484/23/10/105101. [DOI] [PubMed] [Google Scholar]
- 29.Iannazzo D., et al. Synthesis and Anti-HIV activity of carboxylated and drug-conjugated multi-walled carbon nanotubes. Carbon N Y. 2015;82:548–561. doi: 10.1016/j.carbon.2014.11.007. [DOI] [Google Scholar]
- 30.Xu X., et al. Electrophoretic analysis and purification of fluorescent single-walled carbon nanotube fragments. J. Am. Chem. Soc. 2004;126(40):12736–12737. doi: 10.1021/ja040082h. [DOI] [PubMed] [Google Scholar]
- 31.Sun Ya-P, et al. Quantum-sized carbon dots for bright and colorful photoluminescence. J. Am. Chem. Soc. 2006;128(24):7756–7757. doi: 10.1021/ja062677d. [DOI] [PubMed] [Google Scholar]
- 32.Ponomarenko L.A., et al. Chaotic dirac billiard in graphene quantum dots. Science. 2008;320(5874):356–358. doi: 10.1126/science.1154663. [DOI] [PubMed] [Google Scholar]
- 33.Wang D., Chen J.-.F., Dai L. Recent advances in graphene quantum dots for fluorescence bioimaging from cells through tissues to animals. Part. Part. Syst. Charact. 2015;32(5):515–523. doi: 10.1002/ppsc.201400219. [DOI] [Google Scholar]
- 34.Barras A., et al. High efficiency of functional carbon nanodots as entry inhibitors of herpes simplex virus type 1. ACS Appl. Mater. Interfaces. 2016;8(14):1. doi: 10.1021/acsami.6b01681. [DOI] [PubMed] [Google Scholar]
- 35.Fahmi M.Z., et al. Design of boronic acid-attributed carbon dots on inhibits HIV-1 entry. RSC Adv. 2016;6(95) doi: 10.1039/C6RA21062G. 92996–2. [DOI] [Google Scholar]
- 36.Du T., et al. Carbon dots as inhibitors of virus by activation of type I interferon response. Carbon N Y. 2016;110:278–285. doi: 10.1016/j.carbon.2016.09.032. [DOI] [Google Scholar]
- 37.Tong T., et al. Glycyrrhizic-acid-based carbon dots with high antiviral activity by multisite inhibition mechanisms. Small. 2020;16(13) doi: 10.1002/smll.201906206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Lin C.-.J., et al. High amplification of the antiviral activity of curcumin through transformation into carbon quantum dots. Small. 2019;15(41) doi: 10.1002/smll.201902641. [DOI] [PubMed] [Google Scholar]
- 39.Ting Du, et al. Multisite inhibitors for enteric coronavirus: antiviral cationic carbon dots based on Curcumin. ACS Appl. Nano Mater. 2018;1(10):5451–5459. doi: 10.1021/acsanm.8b00779. [DOI] [PubMed] [Google Scholar]
- 40.Łoczechin A., et al. Functional carbon quantum dots as medical countermeasures to human coronavirus. ACS Appl. Mater. Interfaces. 2019;11(46):42964–42974. doi: 10.1021/acsami.9b15032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Huang S., et al. Benzoxazine monomer derived carbon dots as a broad-spectrum agent to block viral infectivity. J. Colloid Interface Sci. 2019;542:198–206. doi: 10.1016/j.jcis.2019.02.010. [DOI] [PubMed] [Google Scholar]
- 42.Dong X., et al. Carbon dots’ antiviral functions against noroviruses. Sci. Rep. 2017;7(1):519. doi: 10.1038/s41598-017-00675-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Ju E., et al. Specific inhibition of viral MicroRNAs by carbon dots-mediated delivery of locked nucleic acids for therapy of virus-induced cancer. ACS Nano. 2020;14(1):476–487. doi: 10.1021/acsnano.9b06333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Iannazzo D., et al. Graphene quantum dots based systems as HIV inhibitors. Bioconjug. Chem. 2018;29(9):3084–3093. doi: 10.1021/acs.bioconjchem.8b00448. [DOI] [PubMed] [Google Scholar]
- 45.Novoselov K.S., et al. Electric field effect in atomically thin carbon films. Science. 2004;306(5696):666–669. doi: 10.1126/science.1102896. [DOI] [PubMed] [Google Scholar]
- 46.Sametband M., et al. Herpes simplex virus type-1 attachment inhibition by functionalized graphene oxide. ACS Appl. Mater. Interfaces. 2014;6(2):1228–1235. doi: 10.1021/am405040z. [DOI] [PubMed] [Google Scholar]
- 47.Song Z., et al. Virus capture and destruction by label-free graphene oxide for detection and disinfection applications. Small. 2015;11(9–10):1171–1176. doi: 10.1002/smll.201401706. [DOI] [PubMed] [Google Scholar]
- 48.Yang XXi, et al. Synergistic antiviral effect of curcumin functionalized graphene oxide against respiratory syncytial virus infection. Nanoscale. 2017;9(41):16086–16092. doi: 10.1039/C7NR06520E. [DOI] [PubMed] [Google Scholar]
- 49.Krishnamoorthy K., Mohan R., Kim S.-.J. Graphene oxide as a photocatalytic material. Appl. Phys. Lett. 2011;98(24) doi: 10.1063/1.3599453. [DOI] [Google Scholar]
- 50.Hu X., et al. Covalently synthesized graphene oxide-aptamer nanosheets for efficient visible-light photocatalysis of nucleic acids and proteins of viruses. Carbon N Y. 2012;50(8):2772–2781. doi: 10.1016/j.carbon.2012.02.038. [DOI] [Google Scholar]
- 51.Akhavan O., Choobtashani M., Ghaderi E. Protein degradation and RNA Efflux of viruses photocatalyzed by graphene–tungsten oxide composite under visible light irradiation. J. Phys. Chem. C. 2012;116(17):9653–9659. doi: 10.1021/jp301707m. [DOI] [Google Scholar]
- 52.Durmuş S., Ülgen K.Ö. Comparative interactomics for virus–human protein–protein interactions: DNA viruses versus RNA viruses. FEBS Open Bio. 2017;7(1):96–107. doi: 10.1002/2211-5463.12167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Hamblin M.R. Fullerenes as photosensitizers in photodynamic therapy: pros and cons. Photochem. Photobiol. Sci. 2018;17(11):1515–1533. doi: 10.1039/C8PP00195B. [DOI] [PMC free article] [PubMed] [Google Scholar]




